WO2023037026A1 - Revêtement hybride à base d'un mélange de matériau composite adhésif, destiné à être utilisé sur des surfaces d'éléments implantables - Google Patents
Revêtement hybride à base d'un mélange de matériau composite adhésif, destiné à être utilisé sur des surfaces d'éléments implantables Download PDFInfo
- Publication number
- WO2023037026A1 WO2023037026A1 PCT/ES2022/070560 ES2022070560W WO2023037026A1 WO 2023037026 A1 WO2023037026 A1 WO 2023037026A1 ES 2022070560 W ES2022070560 W ES 2022070560W WO 2023037026 A1 WO2023037026 A1 WO 2023037026A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- adhesive
- sol
- hybrid
- doi
- https
- Prior art date
Links
- 238000000576 coating method Methods 0.000 title claims abstract description 31
- 239000000853 adhesive Substances 0.000 title claims abstract description 29
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 29
- 239000011248 coating agent Substances 0.000 title claims abstract description 26
- 239000002131 composite material Substances 0.000 title abstract description 4
- 239000000203 mixture Substances 0.000 title description 12
- 239000000463 material Substances 0.000 claims abstract description 50
- 229920001661 Chitosan Polymers 0.000 claims description 19
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 11
- 229920006332 epoxy adhesive Polymers 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 230000001404 mediated effect Effects 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 abstract description 9
- 239000000945 filler Substances 0.000 abstract description 2
- 230000002138 osteoinductive effect Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000008595 infiltration Effects 0.000 abstract 1
- 238000001764 infiltration Methods 0.000 abstract 1
- 239000007943 implant Substances 0.000 description 19
- 238000000034 method Methods 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 12
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 11
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 11
- 230000000975 bioactive effect Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000004964 aerogel Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000012620 biological material Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000003833 cell viability Effects 0.000 description 5
- 239000003822 epoxy resin Substances 0.000 description 5
- 239000002105 nanoparticle Substances 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 229920000647 polyepoxide Polymers 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229910052719 titanium Inorganic materials 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000002372 labelling Methods 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 231100000433 cytotoxic Toxicity 0.000 description 3
- 230000001472 cytotoxic effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007769 metal material Substances 0.000 description 3
- 230000001582 osteoblastic effect Effects 0.000 description 3
- 230000035899 viability Effects 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- JUPQTSLXMOCDHR-UHFFFAOYSA-N benzene-1,4-diol;bis(4-fluorophenyl)methanone Chemical compound OC1=CC=C(O)C=C1.C1=CC(F)=CC=C1C(=O)C1=CC=C(F)C=C1 JUPQTSLXMOCDHR-UHFFFAOYSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003570 cell viability assay Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 238000002784 cytotoxicity assay Methods 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 239000004053 dental implant Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229940005740 hexametaphosphate Drugs 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 230000002188 osteogenic effect Effects 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 239000004848 polyfunctional curative Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 231100000747 viability assay Toxicity 0.000 description 2
- 238000003026 viability measurement method Methods 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229910020676 Co—N Inorganic materials 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000004965 Silica aerogel Substances 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229920004738 ULTEM® Polymers 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007171 acid catalysis Methods 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002048 anodisation reaction Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 239000011173 biocomposite Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 238000010883 osseointegration Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000007750 plasma spraying Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910002028 silica xerogel Inorganic materials 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000011883 total knee arthroplasty Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
Definitions
- the present invention belongs to the field of adhesive technology, tissue engineering and biomechanics.
- the technical object consists of a composite material made up of a mixture of an epoxy-type adhesive and a certain sol-gel material, which is applied as a coating on implantable elements in the biomedical, trauma, orthopedics, and oral industries.
- prostheses in traumatology for example: in ATR total knee arthroplasty, or ATC hip
- materials used have been based on stainless steels, titanium alloys, Cr-Co-N ⁇ alloys and other dangerous metals for humans (Keegan, Learmonth, & Case, 2007).
- the problem arises from a lack of proven biocompatibility in the medium or long term.
- an increase in their useful life is sought, facilitating their integration into the bone by incorporating a cemented material to the implantable surfaces, which serves as a real osteoinductive barrier and protects against infections.
- the surface of the implant is considered to be that which will be in direct contact with the oral tissues, either the soft tissues (gum and connective tissue), or the hard tissues (bone).
- the biology of both is totally different, so the part of the implant that has to come into contact with them has been modified to allow a greater interrelation between them.
- the surface of the implants can be classified as smooth or treated.
- the smooth one is one that has not undergone more processing than that of the manufacture since the turning of the bar. It is almost flat, with only the roughness typical of the passage of the drill and has a lower incidence in bone formation. It is used to be the one that is in contact with the soft tissues, in order to obtain a possible union with them and an area that is easier to clean.
- the treated one is irregular and seeks union with the bone tissue.
- the pattern obtained will depend on the way in which the smooth surface is modified to reach it, which may be with addition methods (plasma, material coating, anodization,%), subtraction (shot blasting, acid etching, laser , ...), oxidation or mixed (combination of several). Implants obtained by synthesizing always give a rough finish on their surface and must be reworked to smooth it out. In the case of coatings, these are usually porous, based on hydroxyapatite (HA), made by diffusion and by plasma spraying (Heimann, 2016).
- HA hydroxyapatite
- the reference [RU2684617C1] describes a method for applying a bioactive coating on titanium implants, the coating is a electrolyte composed of orthophosphoric acid, hydroxyapatite (HA, Cas(PO4)3(OH)), germanium and distilled water.
- the reference refers to a hybrid coating material made up of a silicon xerogel and chitosan to coat surfaces of titanium implants.
- the consulted bibliography does not report cases of obtaining a hybrid coating material made up of a mixture of an epoxy resin-based adhesive with an airgel or a TEOS xerogel and chitosan, such as the one described in this invention.
- This material potentially plays an active role in the biomineralization of HA, being capable of inducing its nucleation and growth on the surface of the material.
- the adhesive hybrid biomatenals and biocomposites resulting from the processing described in this Report avoid the main problems that arise with implants based on metallic materials such as stainless steel, titanium or chrome alloys - cobalt-nickel, which do not guarantee bone formation and cause problems in the vicinity of surgery and, above all, corrosion phenomena.
- the invention demonstrates the possibility of coating non-bioactive and non-biodegradable metal surfaces in implantable elements with these characteristics, but with the guarantee of not suffering detachments.
- the invention develops a method for obtaining a hybrid biomaterial composed of a synthesized aerogel/xerogel based on tetraethylorthosilicate (TEOS) and chitosan, with a solid bond mediated by an epoxy adhesive.
- TEOS tetraethylorthosilicate
- chitosan a solid bond mediated by an epoxy adhesive.
- the hybrid adhesive biomaterial can be applied to any metallic or non-metallic implant or prosthesis of the hip, knee, shoulder, etc.
- the proposed hybrid coating is the result of mixing a sol-gel material (airgel or xerogel) and a commercial medical grade epoxy resin, beginning with the manufacture of airgel or xerogel.
- the sol-gel technique has been selected, which is quite versatile since it allows obtaining hybrid materials by combining organic and inorganic compounds until the desired physicochemical and biological properties are achieved.
- the components of the material will be tetraethylorthosilicate (TEOS) and chitosan.
- TEOS through the acid catalysis of hydrochloric acid (HCI), will react and form a silica network.
- Silica is known to be a bioactive material, that is, if it is introduced into simulated biological fluid, it is capable of growing hydroxyapatite (HA) on its surface (Gótz, Tobiasch, Witzleben, & Schulze, 2019).
- HA is the mineral component of bone, so if by simulating the physiological conditions of the human body it is able to grow on the material, it will also grow once it is introduced into the body.
- chitosan is a biopolymer found in the shell of crustaceans. This compound is biocompatible, biodegradable and favors cell adhesion (Preethi Soundarya, Haritha Menon, Viji Chandran, & Selvamurugan, 2018) (Turnbull et al., 2018).
- the adhesive used is a medical grade epoxy called LOCTITE® M31 CLTM from the manufacturer HENKEL IBÉRICA, SA.
- the sol-gel material is obtained, it is manually ground in an agate mortar.
- the aerogel/xerogel is mixed manually with the biocompatible epoxy adhesive until a hybrid material with a homogeneous texture is obtained.
- the adhesive affects the properties of aerogels and xerogels, one of the compositions described in the reference given above has been selected, in this case, 4% chitosan, to carry out the different tests. The results obtained can be extrapolated to the rest of the compositions as they are all bioactive and non-cytotoxic.
- the mixture with the adhesive was carried out following different proportions for aerogel and xerogel, since they have different densities and specific surfaces, as shown in Table 1, which affects their behavior.
- a n R and X m R where A refers to aerogel and X to xerogel, where n and m are the ratio by weight of airgel: resin and xerogel resin, respectively.
- the proportions prepared appear in Table 2. These mixtures cure in 90 minutes at 50°C and have withstood the autoclaving process without deformation or phase changes.
- cell cultures with COPH are carried out in the presence of the different biomaterials to determine if the material affects cell viability.
- COPH were cultured in osteogenic media and viability/cytotoxicity assays were performed at 7 days.
- LIVE/DEAD dead cells are labeled with EthD-1 and live cells with Calcein AM.
- Calcein AM live cells with Calcein AM.
- COPH cultures were incubated with 70% methanol for 30 minutes. Cultures of COPH without any treatment were used as a positive control.
- the culture medium was removed, then they were washed with PBS and finally the labeling solution was added. After a 30 minute incubation at room temperature, they were observed under fluorescence microscopy.
- the material is synthesized from a 2% by weight chitosan solution in 0.5M acetic acid to which GPTMS is added in a 2:1 GPTMS/chitosan molar ratio and a solution of hydrolyzed TEOS under the catalytic effect of ultrasonic high power with 0.1 M hydrochloric acid. Subsequently, both solutions are mixed until obtaining 4% by weight of chitosan with respect to silica. This mixture is allowed to stir for 30 minutes and then it is poured into cylindrical plastic cans and left in an oven for 10 days at 50°C where they will gel. After this time, the samples are introduced into ethanol. Then drying takes place. In this case, it is dried with CO2 under supercritical conditions. In this way, an airgel with 4% chitosan with respect to silica and a GPTMS: chitosan 2:1 molar ratio is obtained.
- This material is hand-ground to a powder and mixed with the adhesive at an airgel:adhesive weight ratio of 0.25:1. Once a homogeneous mixture is obtained, it is applied to the surface of a titanium sample and allowed to dry for 24 hours. Subsequently, it is introduced into SBF and it is observed that it grows after 7 days immersed, HA appears on its surface, as observed by microscopy. scanning electron (see Figure 1 j) k) ), demonstrating that the A0.25R material is bioactive.
- cell cultures are performed with COPH in the presence of the different biomaterials.
- COPH were cultured in osteogenic media and viability/cytotoxicity assays were performed at 7 days.
- this assay called LIVE/DEAD, dead cells are labeled with EthD-1 and live cells with Calcein AM.
- EthD-1 live cells with Calcein AM.
- Calcein AM Calcein AM
- the culture medium was removed, then they were washed with PBS and finally the labeling solution was added. After a 30 minute incubation at room temperature, they were observed under fluorescence microscopy.
- the other materials have a similar cell compatibility to the COPH in a state of normal growth (positive control), and therefore, in these tests we can rule out that these materials have any effect cytotoxic in human osteoblastic cells, as we observed in the negative control (70% Methanol). Mode in which the invention is capable of industrial application
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Adhesives Or Adhesive Processes (AREA)
Abstract
Le revêtement hybride adhésif/sol-gel est un matériau composite ayant des caractéristiques biocompatibles et ostéo-conductrices depuis les premières 24 heures de son application sur des surfaces implantables ou comme remplissage osseux indépendant, ce dernier se comportant comme un matériau qui se solidifie en moins de 3 heures et, du fait qu'il présente des mésopores sur tout son volume, accepte l'infiltration de sang du patient qui subit une intervention chirurgicale.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES202130841A ES2935742B2 (es) | 2021-09-09 | 2021-09-09 | Recubrimiento hibrido basado en una mezcla de material compuesto adhesivo, para aplicacion en superficies de elementos implantables |
ESP202130841 | 2021-09-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023037026A1 true WO2023037026A1 (fr) | 2023-03-16 |
Family
ID=85413463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2022/070560 WO2023037026A1 (fr) | 2021-09-09 | 2022-09-05 | Revêtement hybride à base d'un mélange de matériau composite adhésif, destiné à être utilisé sur des surfaces d'éléments implantables |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2935742B2 (fr) |
WO (1) | WO2023037026A1 (fr) |
-
2021
- 2021-09-09 ES ES202130841A patent/ES2935742B2/es active Active
-
2022
- 2022-09-05 WO PCT/ES2022/070560 patent/WO2023037026A1/fr unknown
Non-Patent Citations (5)
Title |
---|
GUZEL KAYA GULCIHAN, YILMAZ ELIF, DEVECI HUSEYIN: "Sustainable nanocomposites of epoxy and silica xerogel synthesized from corn stalk ash: Enhanced thermal and acoustic insulation performance", COMPOSITES PART B, ELSEVIER, AMSTERDAM, NL, vol. 150, 1 October 2018 (2018-10-01), AMSTERDAM, NL, pages 1 - 6, XP093047398, ISSN: 1359-8368, DOI: 10.1016/j.compositesb.2018.05.039 * |
HYUNG MIN KIM, KIM HYUN SU, KIM SEONG YUN, YOUN JAE RYOUN: "Silica aerogel/epoxy composites with preserved aerogel pores and low thermal conductivity", E-POLYMERS, WALTER DE GRUYTER GMBH, DE, vol. 15, no. 2, 14 February 2015 (2015-02-14), DE , XP055434495, ISSN: 2197-4586, DOI: 10.1515/epoly-2014-0165 * |
JUN, S.H. ; LEE, E.J. ; YOOK, S.W. ; KIM, H.E. ; KIM, H.W. ; KOH, Y.H.: "A bioactive coating of a silica xerogel/chitosan hybrid on titanium by a room temperature solgel process", ACTA BIOMATERIALIA, ELSEVIER, AMSTERDAM, NL, vol. 6, no. 1, 1 January 2010 (2010-01-01), AMSTERDAM, NL, pages 302 - 307, XP026781991, ISSN: 1742-7061, DOI: 10.1016/j.actbio.2009.06.024 * |
PALLA-RUBIO B., ARAÚJO-GOMES N., FERNÁNDEZ-GUTIÉRREZ M., ROJO L., SUAY J., GURRUCHAGA M., GOÑI I.: "Synthesis and characterization of silica-chitosan hybrid materials as antibacterial coatings for titanium implants", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS , LTD BARKING, GB, vol. 203, 1 January 2019 (2019-01-01), GB , pages 331 - 341, XP093047402, ISSN: 0144-8617, DOI: 10.1016/j.carbpol.2018.09.064 * |
REYES-PECES MARÍA V., PÉREZ-MORENO A., DE-LOS-SANTOS DESEADA MARÍA, MESA-DÍAZ MARÍA DEL MAR, PINAGLIA-TOBARUELA GONZALO, VILCHES-P: "Chitosan-GPTMS-Silica Hybrid Mesoporous Aerogels for Bone Tissue Engineering", POLYMERS, MOLECULAR DIVERSITY PRESERVATION INTERNATIONAL (M DP I) AG., CH, vol. 12, no. 11, 1 November 2020 (2020-11-01), CH , pages 2723 - 24, XP093047393, ISSN: 2073-4360, DOI: 10.3390/polym12112723 * |
Also Published As
Publication number | Publication date |
---|---|
ES2935742B2 (es) | 2023-07-28 |
ES2935742A1 (es) | 2023-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Najeeb et al. | Applications of polyetheretherketone (PEEK) in oral implantology and prosthodontics | |
Chopra et al. | Advancing dental implants: Bioactive and therapeutic modifications of zirconia | |
Civantos et al. | Titanium coatings and surface modifications: toward clinically useful bioactive implants | |
Liu et al. | The physicochemical/biological properties of porous tantalum and the potential surface modification techniques to improve its clinical application in dental implantology | |
Jiang et al. | Design of dental implants at materials level: An overview | |
Park et al. | Osteoblast response and osseointegration of a Ti–6Al–4V alloy implant incorporating strontium | |
Shadanbaz et al. | Calcium phosphate coatings on magnesium alloys for biomedical applications: a review | |
Gu et al. | Bioinspired modifications of PEEK implants for bone tissue engineering | |
Barrère et al. | Osteogenecity of octacalcium phosphate coatings applied on porous metal implants | |
Zan et al. | Effect of roughness on in situ biomineralized CaP-collagen coating on the osteogenesis of mesenchymal stem cells | |
US11629055B2 (en) | Magnesium phosphate hydrogels | |
Najeeb et al. | Dental implants materials and surface treatments | |
Li et al. | Bending properties, compression properties, biocompatibility and bioactivity of sulfonated carbon fibers/PEEK composites with graphene oxide coating | |
Paul et al. | Human gingival fibroblast proliferation on materials used for dental implant abutments: a systematic review. | |
Sun et al. | Surface modifications for zirconia dental implants: a review | |
Seyedmajidi et al. | Fluorapatite: A Review of Synthesis, Properties and Medical Applications vs Hydroxyapatite. | |
He et al. | Design of cefotaxime sodium-loaded polydopamine coatings with controlled surface roughness for titanium implants | |
Kumar et al. | Hydroxyapatite and nanocomposite implant coatings | |
ES2935742B2 (es) | Recubrimiento hibrido basado en una mezcla de material compuesto adhesivo, para aplicacion en superficies de elementos implantables | |
Park | Osseointegration of two different phosphate ion‐containing titanium oxide surfaces in rabbit cancellous bone | |
Mishra¹ et al. | Bioceramics for adhesive applications | |
O’Sullivan et al. | Inorganic biomaterials to support the formation and repair of bone tissue | |
Dorozhkin | Surface modification of magnesium and its biodegradable alloys by calcium orthophosphate coatings to improve corrosion resistance and biocompatibility | |
Mur | Accelerating mineralization of biomimetic surfaces | |
Yang et al. | Biocompatibility of surface-modified magnesium and magnesium alloys |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22866814 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |